[HTML][HTML] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …

RPJ Schroeder, WM Van Weerden… - European journal of …, 2011 - Springer
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

RP Schroeder, WM van Weerden… - European Journal of …, 2011 - europepmc.org
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

RPJ Schroeder, WM Weerden… - … Journal of Nuclear …, 2011 - search.ebscohost.com
Purpose: Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

[PDF][PDF] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …

RPJ Schroeder, WM van Weerden… - Eur J Nucl Med Mol …, 2011 - cyberleninka.org
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

RPJ Schroeder, WM van Weerden… - European Journal of …, 2011 - inis.iaea.org
[en] Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-releasing
peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a promising …

[PDF][PDF] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …

RPJ Schroeder, WM van Weerden… - Eur J Nucl Med Mol …, 2011 - academia.edu
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

RP Schroeder, WM van Weerden… - European Journal of …, 2011 - hero.epa.gov
Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-releasing
peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a promising …

[PDF][PDF] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …

RPJ Schroeder, WM van Weerden, EP Krenning… - Eur J Nucl Med Mol …, 2011 - Citeseer
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

RPJ Schroeder, WM van Weerden… - … journal of nuclear …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human …

P Rogier, J Schroeder… - … Journal of Nuclear …, 2011 - search.proquest.com
Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-releasing
peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a promising …